SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001388410-17-000013
Filing Date
2017-05-04
Accepted
2017-05-03 21:53:31
Documents
4
Period of Report
2017-04-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f20170503prlx8kcbeditfinal.htm 8-K 23224
2 EX 10.34 CONSULTING AGREEMENT ex1034consultingagreement.htm EX-10 45426
3 EX 10.33 IP PURCHASE AGREEMENT ex1033purchaseagreement.htm EX-10 189152
4 IMAGE f20170503prlx8kcbeditfina001.jpg GRAPHIC 15743
  Complete submission text file 0001388410-17-000013.txt   281203
Mailing Address 1327 OCEAN AVENUE, SUITE M SANTA MONICA CA 90401
Business Address 1327 OCEAN AVENUE, SUITE M SANTA MONICA CA 90401 310-899-4442
PARALLAX HEALTH SCIENCES, INC. (Filer) CIK: 0001388410 (see all company filings)

IRS No.: 721619357 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-52534 | Film No.: 17811624
SIC: 5912 Retail-Drug Stores and Proprietary Stores